Related Experiment Videos
Summary
Total pancreatectomy (TP) for pancreatic tumors has a 20% overall lethality, but elective TP shows improved outcomes. Metabolic changes like exocrine insufficiency and diabetes are common after TP.
Area of Science:
- Oncology
- Gastroenterology
- Surgical Oncology
Background:
- Pancreatic tumors necessitate complex surgical interventions.
- Total pancreatectomy (TP) is a radical procedure for advanced pancreatic malignancies.
- Evaluating TP outcomes is crucial for patient management.
Purpose of the Study:
- To analyze lethality, morbidity, survival, and metabolic consequences of total pancreatectomy (TP).
- To assess the feasibility and outcomes of TP in a Ukrainian specialized center.
Main Methods:
- Retrospective analysis of 35 total pancreatectomy (TP) operations.
- Inclusion of both urgent and elective TP procedures.
- Evaluation of post-operative lethality, complications, survival rates, and metabolic sequelae.
Main Results:
- Overall lethality was 20% (7/35), with elective TP showing lower lethality (6.7%, 2/30).
- Complication rate for elective TP was 40%.
- Median survival was 18 months, with 3-year survival at 40% and 5-year survival at 13.3%.
Conclusions:
- Total pancreatectomy (TP) is a viable option in specialized Ukrainian centers, with outcomes comparable to international standards.
- Pancreatic exocrine insufficiency, pancreatogenic diabetes, and lipid metabolism changes are frequent post-TP metabolic consequences.
- Elective TP demonstrates improved survival and reduced lethality compared to urgent TP.